The Repression of Hormone-activated PEPCK Gene Expression by Glucose Is Insulin-independent but Requires Glucose Metabolism*

Abstract

Phosphoenolpyruvate carboxykinase (PEPCK) is a rate-controlling enzyme in hepatic gluconeogenesis, and it therefore plays a central role in glucose homeostasis. The rate of transcription of the PEPCK gene is increased by glucagon (via cAMP) and glucocorticoids and is inhibited by insulin. Under certain circumstances glucose also decreases PEPCK gene expression, but the mechanism of this effect is poorly understood. The glucose-mediated stimulation of a number of glycolytic and lipogenic genes requires the expression of glucokinase (GK) and increased glucose metabolism. HL1C rat hepatoma cells are a stably transfected line of H4IIE rat hepatoma cells that express a PEPCK promoter-chloramphenicol acetyltransferase fusion gene that is regulated in the same manner as the endogenous PEPCK gene. These cells do not express GK and do not normally exhibit a response of either the endogenous PEPCK gene, or of thetrans-gene, to glucose. A recombinant adenovirus that directs the expression of glucokinase (AdCMV-GK) was used to increase glucose metabolism in HL1C cells to test whether increased glucose flux is also required for the repression of PEPCK gene expression. In AdCMV-GK-treated cells glucose strongly inhibits hormone-activated transcription of the endogenous PEPCK gene and of the expressed fusion gene. The glucose effect on PEPCK gene promoter activity is blocked by 5 mm mannoheptulose, a specific inhibitor of GK activity. The glucose analog, 2-deoxyglucose mimics the glucose response, but this effect does not require GK expression. 3-O-methylglucose is ineffective. Glucose exerts its effect on the PEPCK gene within 4 h, at physiologic concentrations, and with an EC50 of 6.5 mm, which approximates theK m of glucokinase. The effects of glucose and insulin on PEPCK gene expression are additive, but only at suboptimal concentrations of both agents. The results of these studies demonstrate that, by inhibiting PEPCK gene transcription, glucose participates in a feedback control loop that governs its production from gluconeogenesis.

Footnotes

  • * This work was supported in part by National Institutes of Health Grants DK35107 (to D. K. G. and D. K. S.) and P50H2598801 (to C. B. N.), and by an American Physiological Society/Genentech Inc. fellowship (to R. M. O’D.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • To whom correspondence should be addressed. Tel.: 615-322-7004; Fax: 615-322-7236; E-mail:daryl.granner{at}mcmail.vanderbilt.edu.

  • Abbreviations:
    PEPCK

    phosphoenolpyruvate carboxykinase

    S14

    spot 14

    GK

    glucokinase

    Glu-6-P

    glucose 6-phosphate

    dexamethasone/cAMP

    dexamethasone and 8-(-chlorophenyl-thio)cAMP

    ChoRE

    carbohydrate response element

    CAT

    chloramphenicol acetyltansferase

    β-Gal

    β-galactosidase.

    • Received November 26, 1997.
    • Revision received June 2, 1998.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement